Real-world analysis of three years of closed claims data from Symphony Health focused on the third year of the study (2023-2024), comprised of ...
Zacks Small Cap Research on MSN
TNXP: Secures commercial payer coverage for Tonmya® to provide access for ~35 million US patients
By David Bautz, PhD NASDAQ: TNXP READ THE FULL TNXP RESEARCH REPORT Business Update Tonmya™ Update Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is continuing the commercial launch of Tonmya® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results